Mycophenolate mofetil vs methotrexate
Prevention of chronic GVHD · people receiving allogeneic hematopoietic stem cell transplantation
Mycophenolate mofetil showed no clear difference in prevention of chronic GVHD compared with methotrexate (low certainty).
1 finding from 1 review
- Mycophenolate mofetil versus methotrexate for prevention of graft‐versus‐host disease in people receiving allogeneic… 2014 · Cochrane Headline outcomes onlyRR 0.92 [0.65, 1.3]2 studies · 129 participantsLow